The top gainers for today include BioMarin Pharmaceutical Inc. BMRN from the sector Healthcare with a gain of -0.86%. The price is $ 90.17, at present and the target price is $ 111.2.
The weekly performance for BioMarin Pharmaceutical Inc. is 1.85%, which is not surprising given the gain it made today.
The earnings per share (EPS) growth forecasted for 2016 is currently 62.10%. The earnings per share quarter to quarter growth is -207.50%
The simple 20 day moving average is up by 2.30% and the 52-week low is 22.76%.
The monthly and quarterly performance for BioMarin Pharmaceutical Inc. is not as bright as it currently stands at 0.19% and 3.45%. However it is poised to change given the current performance trend.
BioMarin Pharmaceutical Inc. has a total market capitalization of 15587.69 with a return on assets (ROA – calculated by dividing the total annual earnings by the company’s total assets – illustrates how profitable a company really is in relation to its total assets) of -17.20%. It has a dividend yield of *TBA while the payout ratio is *TBA.
BioMarin Pharmaceutical Inc. has a gross margin of 81.20% and an operating margin of -71.90%. The net profit margin stands at -56.40%.
The weekly volatility is 2.24% and the monthly volatility is 2.02%. Volatility is basically a statistical measure of the dispersion of returns for a given security or market index. It can be either be measured by implementing the standard deviation or by simply calculating the variance between returns from that market index.